Your browser is no longer supported. Please, upgrade your browser.
Settings
GLQ Clough Global Equity Fund daily Stock Chart
GLQ [NYSE]
Clough Global Equity Fund
Index- P/E- EPS (ttm)-1.07 Insider Own8.25% Shs Outstand17.65M Perf Week2.34%
Market Cap224.20M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month5.88%
Income- PEG- EPS next Q- Inst Own26.50% Short Float- Perf Quarter13.65%
Sales5.94M P/S37.76 EPS this Y- Inst Trans-9.91% Short Ratio0.18 Perf Half Y24.15%
Book/sh12.70 P/B1.00 EPS next Y- ROA- Target Price- Perf Year31.26%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range9.30 - 12.60 Perf YTD17.94%
Dividend1.19 P/FCF- EPS past 5Y0.00% ROI- 52W High0.80% Beta-
Dividend %9.37% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low36.56% ATR0.13
Employees- Current Ratio- Sales Q/Q16.60% Oper. Margin- RSI (14)73.89 Volatility0.79% 1.06%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.27 Prev Close12.59
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume66.17K Price12.70
Recom- SMA202.58% SMA504.90% SMA20015.96% Volume18,002 Change0.87%
Apr-24-17 06:11PM  Clough Global Closed End Funds Announce Portfolio Manager Departure and Appointment of New Interested Trustee Business Wire
Mar-31-17 10:00AM  Clough Global Equity Fund Business Wire
Feb-28-17 10:00AM  Clough Global Equity Fund Business Wire
Feb-06-17 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.0989 Per Share Business Wire
Jan-31-17 10:00AM  Clough Global Equity Fund Business Wire
Jan-30-17 02:16PM  Saba Capital Management Invests in Clough Global Equity Fund GuruFocus.com
Jan-25-17 04:43PM  Clough Global Closed End Funds Portfolio Manager Departure Business Wire
Dec-30-16 10:00AM  Clough Global Equity Fund Business Wire
Dec-15-16 01:04PM  CLOUGH GLOBAL EQUITY FUND Financials
Dec-14-16 09:00AM  Clough Global Closed End Funds Boards of Trustees Reauthorize Share Repurchase Programs Business Wire
Nov-30-16 10:00AM  Clough Global Equity Fund Business Wire
Nov-07-16 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.0989 Per Share Business Wire
Oct-31-16 10:00AM  Clough Global Equity Fund Business Wire
Sep-30-16 10:00AM  Clough Global Equity Fund Business Wire
Aug-31-16 10:00AM  Clough Global Equity Fund Business Wire
Aug-08-16 09:30AM  Clough Global Equity Fund Announces Fund Distribution Rate Change and Declares Monthly Cash Distribution Business Wire
Jul-29-16 10:00AM  Clough Global Equity Fund Business Wire
Jun-30-16 10:00AM  Clough Global Equity Fund Business Wire
May-31-16 10:00AM  Clough Global Equity Fund Business Wire
May-06-16 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Apr-29-16 09:30AM  Clough Global Equity Fund Business Wire
Mar-31-16 09:35AM  Clough Global Equity Fund Business Wire
Mar-09-16 09:30AM  Clough Global Closed End Funds Boards of Trustees Reauthorize Share Repurchase Programs Business Wire
Feb-29-16 09:35AM  Clough Global Equity Fund Business Wire
Feb-08-16 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Jan-29-16 09:30AM  Clough Global Equity Fund Business Wire
Dec-31-15 10:00AM  Clough Global Equity Fund Business Wire
Nov-30-15 10:00AM  Clough Global Equity Fund Business Wire
Nov-05-15 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Oct-30-15 10:00AM  Clough Global Equity Fund Business Wire
Sep-30-15 09:35AM  Clough Global Equity Fund Business Wire
Aug-31-15 09:30AM  Clough Global Equity Fund Business Wire
Aug-05-15 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Jul-31-15 09:35AM  Clough Global Equity Fund Business Wire
Jul-29-15 04:00PM  Clough Global Equity Fund Announces Voting Results from 2015 Annual Shareholder Meeting Business Wire
Jul-07-15 05:10PM  Clough Global Equity Fund Announces Annual Shareholder Meeting Business Wire
Jun-30-15 09:35AM  Clough Global Equity Fund Business Wire
May-29-15 09:30AM  Clough Global Equity Fund Business Wire
May-11-15 04:00PM  Clough Global Closed-End Funds Approve Participation Agreement Permitting Increased Share Purchases by RiverNorth Funds Business Wire
May-08-15 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.115 Per Share Business Wire
Apr-30-15 09:30AM  Clough Global Equity Fund Business Wire
Apr-20-15 04:00PM  Clough Global Closed-End Funds Adopt Share Repurchase Programs Business Wire
Mar-31-15 10:00AM  Clough Global Equity Fund Business Wire
Feb-27-15 09:30AM  Clough Global Equity Fund Business Wire
Jan-30-15 09:30AM  Clough Global Equity Fund Business Wire
Jan-05-15 09:30AM  Clough Global Equity Fund Increases Its Monthly Distribution 9.52% to $0.115 Per Share Business Wire
Dec-31-14 09:30AM  Clough Global Equity Fund Business Wire
Dec-11-14 04:15PM  Clough Global Equity Fund Increases Its Monthly Distribution 9.52% to $0.115 Per Share Business Wire
Nov-26-14 10:00AM  Clough Global Equity Fund Business Wire
Oct-31-14 09:30AM  Clough Global Equity Fund Business Wire
Oct-07-14 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.105 Per Share Business Wire
Sep-30-14 09:30AM  Clough Global Equity Fund Business Wire
Sep-12-14 09:30AM  Clough Global Equity Fund Announces Change to Fiscal Year End Business Wire
Aug-29-14 09:30AM  Clough Global Equity Fund Business Wire
Jul-31-14 09:30AM  Clough Global Equity Fund Business Wire
Jul-15-14 10:05AM  Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: GLQ, HIO, ISD at TheStreet
Jul-08-14 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.105 Per Share Business Wire
Jun-30-14 09:30AM  Clough Global Equity Fund Business Wire
Jun-13-14 10:00AM  Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Monday: GLQ, AIF, TCPC at TheStreet
Jun-01-14 05:49AM  How I Made 7% Retirement Income Investing In CEFs at Seeking Alpha
May-30-14 09:30AM  Clough Global Equity Fund Business Wire
May-13-14 10:05AM  3 Stocks With Upcoming Ex-Dividend Dates: GLQ, BGCP, CNW at TheStreet
Apr-30-14 09:30AM  Clough Global Equity Fund Business Wire
Apr-07-14 09:30AM  Clough Global Equity Fund Declares a Monthly Cash Distribution of $0.105 Per Share Business Wire
Mar-31-14 10:00AM  Clough Global Equity Fund Business Wire
Mar-13-14 10:00AM  Dividend Watch: 3 Stocks Going Ex-Dividend Friday: GLQ, DHY, PHD at TheStreet
Feb-28-14 09:30AM  Clough Global Equity Fund Business Wire
Feb-11-14 10:03AM  Tomorrow's Ex-Dividends To Watch: GLQ, MEN, MYD, BKH, AMP at TheStreet
Jan-31-14 09:00AM  Clough Global Equity Fund Business Wire
Jan-15-14 09:30AM  Clough Global Equity Fund Business Wire
Jan-14-14 10:00AM  Tomorrow's Ex-Dividends To Watch: GLQ, GNT, LDP, PKI, GMCR at TheStreet
Jan-06-14 10:00AM  3 With Upcoming Ex-Dividend Dates: GLQ, BSBR, NTAP at TheStreet
Dec-19-13 02:16PM  Clough Global Equity Fund Declares Final Quarterly Cash Distribution of $0.29 Per Share before Moving to New Monthly Distributions Business Wire
Dec-12-13 06:30AM  Clough Global Equity Fund Announces an Annual Increase in Cash Distribution Per Common Share and Changes Distribution Payments to Monthly Business Wire
Nov-26-13 01:27PM  How I Made 7% Income While Lowering Risk at Seeking Alpha
Oct-31-13 09:45AM  Clough Global Equity Fund Business Wire
Oct-09-13 03:02PM  Clough Global Equity Fund Revises Quarterly Cash Distribution Ex-Date and Record Date Business Wire
Oct-08-13 06:30AM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jul-31-13 09:00AM  Clough Global Equity Fund Business Wire
Jul-25-13 03:59AM  The CEF Firecracker at Seeking Alpha
Jul-24-13 09:28AM  A High Income, Lower Risk CEF Portfolio For Retirees at Seeking Alpha
Jul-09-13 06:01PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Apr-30-13 07:00AM  Clough Global Equity Fund Business Wire
Apr-16-13 10:00AM  Clough Global Allocation Fund, Clough Global Equity Fund and Clough Global Opportunities Fund Announces Appointment of Vincent W. Versaci to the Board of Trustees Business Wire
Apr-02-13 12:27PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-31-13 05:32PM  Clough Global Equity Fund Business Wire
Jan-08-13 11:47AM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Oct-05-12 02:40PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Sep-28-12 01:32PM  Clough Global Allocation Fund, Clough Global Equity Fund and Clough Global Opportunities Fund Announces Resignation of Andrew C. Boynton Business Wire
Jul-03-12 09:32AM  A Diversified Approach To International Dividends at Seeking Alpha
Apr-03-12 01:16PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-23-12 07:27AM  Dividend Champs With Yields As High As 11.2% at Seeking Alpha
Jan-10-12 12:41PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-09-12 10:44AM  CEF Weekly Review: Convertibles Shine at Seeking Alpha
Dec-14-11 01:41PM  Clough Capital: 3 Interesting Closed-End Funds Are Quasi Hedge Funds at Seeking Alpha
Oct-28-11 12:00AM  Portfolio Insights by Brett Arends: Turmoil leaves closed-end funds on sale at MarketWatch
Oct-05-11 01:06PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jul-07-11 03:40PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Apr-06-11 12:03PM  Clough Global Equity Fund Declares a Quarterly Cash Distribution of $0.29 Per Share Business Wire
Jan-24-11 03:32PM  Growth Story In China Shifts Focus To Internal Consumer Driven Demand: Exclusive Interview From Eric A. Brock Of Clough Capital Partners Wall Street Transcript
Clough Global Equity Fund is a closed ended equity mutual fund launched and managed by Clough Capital Partners, L.P. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating across diversified sectors. It employs fundamental and quantitative analysis with a bottom up stock picking approach to create its portfolio, with focus on factors such as a company's competitive position, quality of company management, quality and visibility of earnings and cash flow, balance sheet strength, and relative valuation. The fund follows a theme-based investment process which involves focusing on such events as industry consolidation, technological change, an emerging shortage of a product or raw material, and changes in government regulations. It benchmarks the performance of its portfolio against the S&P 500 Index. Clough Global Equity Fund was formed on January 25, 2005 and is domiciled in the United States.
SCMP Sucampo Pharmaceuticals, Inc. daily Stock Chart
SCMP [NASD]
Sucampo Pharmaceuticals, Inc.
Index- P/E23.60 EPS (ttm)0.41 Insider Own0.10% Shs Outstand45.74M Perf Week0.52%
Market Cap443.68M Forward P/E7.51 EPS next Y1.29 Insider Trans-89.04% Shs Float29.77M Perf Month-8.49%
Income18.50M PEG1.69 EPS next Q0.28 Inst Own55.70% Short Float24.46% Perf Quarter-12.61%
Sales230.10M P/S1.93 EPS this Y-42.20% Inst Trans1.01% Short Ratio8.07 Perf Half Y-22.15%
Book/sh3.88 P/B2.50 EPS next Y19.30% ROA3.90% Target Price17.79 Perf Year-13.62%
Cash/sh- P/C- EPS next 5Y14.00% ROE13.80% 52W Range9.30 - 17.55 Perf YTD-28.41%
Dividend- P/FCF62.49 EPS past 5Y24.80% ROI9.60% 52W High-44.73% Beta1.48
Dividend %- Quick Ratio8.80 Sales past 5Y33.30% Gross Margin67.00% 52W Low4.30% ATR0.39
Employees139 Current Ratio9.50 Sales Q/Q31.80% Oper. Margin17.30% RSI (14)39.39 Volatility2.89% 4.26%
OptionableYes Debt/Eq1.74 EPS Q/Q50.30% Profit Margin8.00% Rel Volume0.58 Prev Close9.65
ShortableYes LT Debt/Eq1.74 EarningsMay 03 BMO Payout0.00% Avg Volume901.92K Price9.70
Recom2.30 SMA20-5.25% SMA50-11.22% SMA200-21.07% Volume523,061 Change0.52%
Mar-10-17Reiterated WallachBeth Buy $20 → $15
Mar-09-17Reiterated Mizuho Buy $16 → $14
Mar-06-17Reiterated Mizuho Buy $16
Dec-22-16Upgrade Mizuho Neutral → Buy $16
Nov-15-16Reiterated Maxim Group Buy $17 → $19
Nov-14-16Reiterated Mizuho Neutral $13 → $16
Sep-07-16Initiated Northland Capital Outperform
Aug-04-16Downgrade Mizuho Buy → Neutral $13
Aug-01-16Reiterated Maxim Group Buy $26 → $17
May-05-16Upgrade WallachBeth Hold → Buy $16
Apr-20-16Upgrade Mizuho Neutral → Buy $14
Mar-10-16Reiterated WallachBeth Hold $27 → $16
Mar-09-16Reiterated Maxim Group Buy $25 → $26
Jan-15-16Reiterated Mizuho Neutral $19 → $14
Nov-20-15Initiated Jefferies Hold $19
Nov-13-15Reiterated Mizuho Neutral $22 → $19
Oct-29-15Resumed ROTH Capital Buy $29
Oct-09-15Initiated Mizuho Neutral
Sep-03-15Initiated Leerink Partners Mkt Perform
Aug-27-15Reiterated WallachBeth Hold $24 → $27
Apr-19-17 06:30AM  Sucampo Announces First Quarter 2017 Earnings Call GlobeNewswire
Apr-18-17 06:31AM  New Study Published in PLOS ONE Advances Science Around VTS-270 for Treatment of Niemann-Pick Disease Type C1 GlobeNewswire
Apr-10-17 04:01AM  Sucampo (SCMP) Down 7.6% Since Earnings Report: Can It Rebound? Zacks -7.44%
Apr-07-17 04:51PM  7 of the Worst-Performing Stocks in Gurus' Portfolios GuruFocus.com
Apr-03-17 10:20AM  Sucampo just bought this local rare disease company for $200M at bizjournals.com
10:20AM  Sucampo just bought this local rare disease company for $200M American City Business Journals
06:57AM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisiti
06:30AM  Sucampo Acquires Vtesse Inc. GlobeNewswire
Mar-28-17 04:01PM  Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 16th Annual Needham Healthcare Conference GlobeNewswire
Mar-16-17 05:50PM  Local drug company stocks react to Trump's proposed cuts to NIH, FDA at bizjournals.com
05:50PM  Local drug company stocks react to Trump's proposed cuts to NIH, FDA American City Business Journals
Mar-15-17 05:01PM  Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Oppenheimer 27th Annual Healthcare Conference GlobeNewswire
Mar-14-17 01:04PM  SUCAMPO PHARMACEUTICALS, INC. Financials
10:11AM  Sucampo Pharmaceuticals (SCMP): Moving Average Crossover Alert Zacks
Mar-13-17 08:54AM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-09-17 10:54AM  Sucampo Pharmaceuticals, Inc. :SCMP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017 Capital Cube -6.64%
10:54AM  Sucampo Pharmaceuticals, Inc. :SCMP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017
10:53AM  Sucampo (SCMP) Beats Q4 Earnings, 2017 View Reaffirmed Zacks
Mar-08-17 10:20PM  Edited Transcript of SCMP earnings conference call or presentation 8-Mar-17 1:30pm GMT Thomson Reuters StreetEvents +7.11%
01:21PM  Here's Why Sucampo Pharmaceuticals Rose as Much as 13.3% Today at Motley Fool
10:08AM  Nasdaq Leads On Chips; Dow Dips As Caterpillar Off, Banks Up
09:11AM  Biotech Premarket Movers: Sucampo, Intellia, Cytokinetics
08:30AM  Sucampo Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today
07:07AM  Q4 2016 Sucampo Pharmaceuticals Inc Earnings Release - Before Market Open
06:48AM  Sucampo tops 4Q revenue forecasts
06:36AM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors
06:30AM  Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
Feb-23-17 04:02PM  Sucampo Announces Fourth Quarter and Full Year 2016 Earnings Call GlobeNewswire
Feb-17-17 05:41PM  Sucampo Pharmaceuticals Set to Join S&P SmallCap 600 PR Newswire
02:04PM  Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View
Feb-16-17 04:25PM  Zoetis (ZTS) Beats Q4 Earnings Estimates, Lowers Outlook
Feb-09-17 10:36AM  Glaxo (GSK) Beats on Q4 Earnings, Posts Dismal '17 View
06:30AM  Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Global Healthcare Conference GlobeNewswire
Feb-07-17 10:56AM  Mallinckrodt (MNK) Tops on Earnings in Transition Quarter
Feb-06-17 08:19AM  Portola, HealthCare Royalty Partners Ink $150 Million Deal
Feb-03-17 08:06AM  AMAG Down Despite Positive Data on Makena Auto-Injector
Feb-02-17 09:49AM  Novartis (NVS) Votubia Gets EU Approval for Label Expansion
07:21AM  Catabasis Hits 52-Week Low on Poor DMD Drug Study Data
Jan-31-17 10:45AM  Mylan (MYL) Gets Favorable Verdict for Copaxone in the US
Jan-30-17 04:19PM  Endo (ENDP) Restructures Branded Pharmaceutical Unit (revised)
10:20AM  Celgene (CELG) Gets Favorable CHMP Opinion for Revlimid
Jan-27-17 02:42PM  AbbVie (ABBV) Q4 Earnings Meet Estimates, Revenues Lag
09:05AM  Endo (ENDP) Restructures its Branded Pharmaceutical Unit
Jan-26-17 03:29PM  Celgene (CELG) Misses on Earnings & Revenues, Keeps View
Jan-23-17 05:26PM  Gilead (GILD) HCV Therapy Application Validated in Europe
05:22PM  Bristol-Myers Settles Litigation with Merck for Keytruda
08:28AM  Prima Biomed Initiates Randomized Study for Breast Cancer
Jan-19-17 09:04AM  Apricus (APRI) Stock Gains on Vitaros' Approval in Mexico
Jan-18-17 08:29AM  Agenus, NCI Ink Deal to Evaluate Prophage-Keytruda Combo
08:26AM  Benitec Stock Up on Orphan Drug Status for BB-301 in EU
Jan-17-17 09:30AM  Zacks.com featured highlights: Glaukos, Daqo New Energy, Calavo Growers and Sucampo Pharmaceuticals -5.60%
08:28AM  Key FDA Events to Watch Out for in Q1
Jan-16-17 08:16AM  4 Profitable Stocks with Amazingly High Returns
08:09AM  5 Top Ranked Stocks with Upgraded Broker Ratings to Buy Now
Jan-13-17 09:55AM  Coherus Offers Positive Phase III Data on Humira Biosimilar
Jan-12-17 04:19PM  TherapeuticsMD's Rejoice Study Data Published in Journal
08:43AM  Merck KGaA, Vertex Announce Tie-Up for Oncology Programs
Jan-11-17 04:42PM  Valeant Streamlines Portfolio with Skincare Brands Sale
09:30AM  The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Insulet, Western Refining, PennyMac Mortgage Investment Trust and Extended Stay America
08:27AM  Novo Nordisk (NVO) Fiasp Gets EU Nod for Diabetes in Adults
Jan-10-17 06:03PM  5 Underperformers of 2016: Turnaround Story in 2017?
09:30AM  Zacks.com featured highlights: NVIDIA, Sucampo Pharmaceuticals, Calavo Growers, Tucows and E*TRADE Financial
Jan-09-17 08:23AM  Go Driehaus Way: 5 Momentum Picks
07:32AM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-06-17 10:18AM  Top Ranked Growth Stocks to Buy for January 6th
Jan-04-17 09:30AM  The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen
08:51AM  Why Sucampo Pharmaceuticals (SCMP)Could Be an Impressive Growth Stock
Jan-03-17 08:32AM  3 Overlooked Drug Stocks to Watch Out for in 2017
Dec-29-16 09:30AM  Zacks.com featured highlights: Calavo Growers, Cytokinetics, Sucampo Pharmaceuticals, State National and CryoLife
Dec-28-16 07:37AM  5 Profitable Stocks to Buy for Great Returns
Dec-27-16 04:17PM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi
09:07AM  Portola Betrixaban Accepted for Review in U.S. & EU, Stock Up
07:11AM  4 Top Stocks with Earnings Acceleration to Buy in 2017
Dec-23-16 11:22AM  Trump, Interest Rates And Biotech Investing In 2017 at Forbes
08:35AM  Ironwood, Allergan Report Positive Linzess IBS-C Study Data
Dec-22-16 01:19PM  Sucampo Pharmaceuticals, Inc. (SCMP) Announces Its New Debt Offering Of Convertible Notes at Insider Monkey
09:43AM  Sucampo Pharmaceuticals, Inc. Value Analysis (NASDAQ:SCMP) : December 22, 2016
06:14AM  Sucampo Pharma upgraded by Mizuho
Dec-21-16 04:15PM  Stock Indexes Calm; Southwestern Energy Up 6%
07:32AM  Sucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCMP-US : December 21, 2016
02:00AM  Sucampo Announces Pricing of $260.0 Million 3.25% Convertible Senior Notes due 2021 GlobeNewswire
Dec-20-16 05:40PM  Why NeoPhotonics, Sucampo Pharmaceuticals, and Worthington Industries Slumped Today at Motley Fool -20.48%
02:50PM  Here's Why Sucampo Pharmaceuticals Is Down Over 20% Today at Motley Fool
01:36PM  Dow Flirts With 20,000 As Caterpillar, Goldman Sachs, Nike Score Gains
Dec-19-16 04:06PM  SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +6.03%
04:01PM  Sucampo Announces Proposed Convertible Senior Note Offering GlobeNewswire
01:47PM  Big-Cap Tech Names, Biotechs, Oils Lifting Market
08:47AM  Agios Stops Development of PKR Activator AG-519, Stock Falls
Dec-16-16 08:17AM  Roche (RHHBY) to Terminate Pacifica Bioscience Agreement
Dec-15-16 06:27AM  athenahealth (ATHN) Reaffirms 2016 View, Guides for 2017
Dec-14-16 09:17AM  Envision Healthcare Acquires Desert Mountain Consultants
08:09AM  Eli Lilly (LLY) to Offer Discount on Insulin from January
07:58AM  Kite Pharma Enters into Partnership with Vitruvian Networks
07:39AM  Proteon Slips to 52-Week Low on Kidney Disease Study Data
Dec-13-16 02:04PM  Top 10 Stocks Under $20
11:10AM  Stocks Stay Higher Ahead Of Fed; Dow Starts Eyeing 20,000
Dec-08-16 10:08AM  Pfizer (PFE) Fined for Price Hike of Anti-Epilepsy Drug in UK
09:30AM  Zacks.com featured highlights: Lancaster Colony, Sucampo Pharmaceuticals, Citrix Systems, VMware and Sanchez Energy
09:00AM  Mylan (MYL) Stock Falls on Restructuring Plans, Layoffs
Dec-07-16 10:01AM  5 Stocks to Buy for Remarkable Earnings Growth in 2017 -5.51%
Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing, identifying, acquiring, and marketing medicines that meet unmet medical needs, primarily in gastroenterology, ophthalmology, and oncology-related disorders in the United States, Japan, Switzerland, and internationally. The company's marketed product includes AMITIZA (lubiprostone), a ClC-2 chloride channel activator for the treatment of chronic idiopathic constipation (CIC) in adults, irritable bowel syndrome with constipation in adult women (IBS-C), opioid-induced constipation (OIC)in patients with chronic non-cancer pain, and chronic constipation; and RESCULA (unoprostone isopropyl), a big potassium channel activator for the treatment of glaucoma and ocular hypertension. Its product candidates in clinical development stage comprise Lubiprostone that is in Phase IV clinical trials for the treatment of irritable bowel syndrome with constipation in adult women; Phase III clinical trials for the treatment of pediatric functional constipation and (IBS-C); and completed Phase III clinical trials for the treatment of (CIC) in adults, IBS-C in adult women, and OIC in patients with chronic non-cancer pain, as well as CPP-1X/sulindac combination product, which has completed Phase III clinical trials for the treatment of familial adenomatous polyposis. Sucampo Pharmaceuticals, Inc. was founded in 1996 is headquartered in Rockville, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Getman Daniel PDirectorNov 29Option Exercise6.803,79925,8333,799Nov 30 04:01 PM
Greenleaf PeterCEONov 29Option Exercise6.7582,459556,59884,972Nov 30 04:01 PM
Greenleaf PeterCEONov 29Sale16.7582,4591,381,1882,513Nov 30 04:01 PM
Getman Daniel PDirectorNov 29Sale16.753,79963,6330Nov 30 04:01 PM
Getman Daniel PDirectorNov 28Option Exercise6.8016,201110,16716,201Nov 30 04:01 PM
Greenleaf PeterCEONov 28Option Exercise6.75117,541793,402120,054Nov 30 04:01 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 28Option Exercise8.3324,975208,04228,424Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 28Sale16.7324,975417,8323,449Nov 28 09:30 PM
Greenleaf PeterCEONov 28Sale16.91117,5411,987,6182,513Nov 30 04:01 PM
Getman Daniel PDirectorNov 28Sale16.8916,201273,6350Nov 30 04:01 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 25Option Exercise8.3399,025824,878102,474Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 25Sale15.8899,0251,572,5173,449Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 23Option Exercise8.3326,000216,58029,449Nov 28 09:30 PM
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec.Nov 23Sale15.7726,000410,0203,449Nov 28 09:30 PM
Smith Andrew PChief Financial OfficerNov 15Sale15.581,76627,514348Nov 16 04:01 PM
CS Credit Suisse Group AG daily Stock Chart
CS [NYSE]
Credit Suisse Group AG
Index- P/E- EPS (ttm)-1.30 Insider Own3.10% Shs Outstand2.07B Perf Week7.75%
Market Cap31.70B Forward P/E9.68 EPS next Y1.58 Insider Trans0.00% Shs Float1.93B Perf Month4.23%
Income-2717.90M PEG- EPS next Q- Inst Own3.40% Short Float0.28% Perf Quarter-0.39%
Sales17.41B P/S1.82 EPS this Y23.60% Inst Trans0.18% Short Ratio1.12 Perf Half Y11.61%
Book/sh19.97 P/B0.77 EPS next Y46.03% ROA-0.30% Target Price17.85 Perf Year6.06%
Cash/sh210.49 P/C0.07 EPS next 5Y0.30% ROE-6.20% 52W Range10.01 - 16.17 Perf YTD6.85%
Dividend0.72 P/FCF1.24 EPS past 5Y-24.80% ROI2.90% 52W High-5.44% Beta1.49
Dividend %4.71% Quick Ratio- Sales past 5Y-5.50% Gross Margin- 52W Low52.75% ATR0.32
Employees47170 Current Ratio- Sales Q/Q-15.80% Oper. Margin42.10% RSI (14)61.77 Volatility1.31% 1.46%
OptionableYes Debt/Eq4.61 EPS Q/Q58.60% Profit Margin-15.60% Rel Volume1.05 Prev Close15.07
ShortableYes LT Debt/Eq4.61 EarningsApr 26 BMO Payout- Avg Volume4.77M Price15.29
Recom2.00 SMA204.86% SMA502.26% SMA20010.04% Volume4,986,155 Change1.46%
Feb-17-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-13-17Downgrade Macquarie Neutral → Underperform
Nov-14-16Upgrade BofA/Merrill Neutral → Buy
Nov-10-16Upgrade Keefe Bruyette Mkt Perform → Outperform
Nov-04-16Downgrade Macquarie Outperform → Neutral
Jun-28-16Downgrade RBC Capital Mkts Outperform → Sector Perform
Jun-27-16Downgrade JP Morgan Neutral → Underweight
Jun-13-16Downgrade Keefe Bruyette Outperform → Mkt Perform
May-20-16Upgrade BofA/Merrill Underperform → Neutral
Apr-05-16Downgrade Exane BNP Paribas Neutral → Underperform
Feb-23-16Upgrade Macquarie Underperform → Outperform
Feb-16-16Downgrade JP Morgan Overweight → Neutral
Feb-05-16Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-01-15Upgrade Morgan Stanley Equal-Weight → Overweight
Mar-06-15Downgrade RBC Capital Mkts Outperform → Sector Perform $26
Feb-08-13Reiterated RBC Capital Mkts Outperform $27 → $30
Jan-05-10Initiated Barclays Capital Equal Weight
Nov-02-09Upgrade Citigroup Hold → Buy
Aug-20-09Upgrade FBR Capital Underperform → Mkt Perform
Jul-28-09Downgrade FBR Capital Mkt Perform → Underperform
Apr-25-17 09:15PM  [$$] Credit Suisse Faces Investor Scrutiny With Earnings Report The Wall Street Journal
07:30AM  Today's Research Reports on Deutsche Bank and Credit Suisse as Banks Surge on French Election Results Accesswire
05:29AM  [$$] Credit Suisse Faces Investor Scrutiny With Earnings Report The Wall Street Journal
05:00AM  Credit Suisse Spends to Boost Booming Energy Team Amid Cutbacks Bloomberg
Apr-24-17 07:00PM  The Bullish Case For Oil Is Fading Fast Oilprice.com
01:13PM  [$$] What Credit Suisse Needs to Get Investors Back on Side The Wall Street Journal
Apr-23-17 12:04PM  [$$] Credit Suisse braced for shareholder revolt over executive pay Financial Times
10:25AM  Credit Suisse to make capital hike decision after AGM: report Reuters
10:08AM  Credit Suisse to make capital hike decision after AGM - report Reuters
Apr-21-17 12:45PM  Top 7 Financial Stocks to Own for 2017 TheStreet.com
Apr-20-17 01:55PM  Today's charts: Wal-Mart, Kroger price wars; Apple shares gain; JPMorgan upgrades Gap; CVS cuts back on candy Yahoo Finance
Apr-19-17 10:17AM  Credit Suisse Has Made a Normal Correction TheStreet.com
09:07AM  Will the Most Unloved Bull Market Go Further? Bloomberg Video
07:38AM  Will the European Central Bank Follow the Fed? Market Realist
05:52AM  U.K. Stocks Win Credit Suisse Upgrade on Cheapness, Pound Limits Bloomberg
Apr-18-17 09:52PM  Energuate Trust -- Moody's assigns Ba2 rating to Energuate's senior unsecured guaranteed notes; outlook Stable Moody's
10:20AM  Commodities Decreased in March due to Supply Expectations PR Newswire
09:55AM  Norway's sovereign fund backs Credit Suisse executive pay Reuters
04:01AM  Credit Suisse Pay Cuts Too Little Too Late, Glass Lewis Says Bloomberg
04:01AM  Credit Suisse Bonus Cuts Win Nod From Norway's Wealth Fund Bloomberg
Apr-17-17 02:22PM  CREDIT SUISSE: Alphabet is our No. 1 internet stock pick Business Insider
06:02AM  [$$] Tax evasion issue continues to haunt Swiss banking Financial Times
Apr-15-17 12:33AM  [$$] Credit Suisse to Cut Executive Bonuses by 40% The Wall Street Journal
Apr-14-17 06:41AM  Credit Suisse Execs Agree to Cut Bonuses by 40% Investopedia
05:50AM  [$$] Credit Suisse to Cut Executive Bonuses by 40% The Wall Street Journal
Apr-13-17 06:31PM  Credit Suisse Leaders Cut Their Bonuses 40% After Backlash Bloomberg
01:42PM  Credit Suisse Group AG -- Moody's assigns Ba2(hyb) rating to Credit Suisse Group AG's CHF 200 million high-trigger AT1 capital securities Moody's
12:10PM  Be Afraid! Volatility & Fear Measures Back to Brexit Levels Investopedia
09:56AM  Credit Suisse has its own 'Fear Barometer,' and it's flashing red Business Insider
03:17AM  Five Charts That Show Fear Is Rearing Its Head in Global Markets Bloomberg
03:17AM  Fear Is Creeping Back Into Markets Bloomberg
Apr-12-17 10:07PM  Credit Suisse Banks on Asia's Entrepreneurs Barrons.com
02:02PM  Fired Banker Sues Credit Suisse After Rogue-Trader Case Collapse Bloomberg
Apr-10-17 07:49PM  Bond Rigging Suit Quotes Cache of Chats to Boost Accusation Bloomberg
Apr-07-17 09:20AM  Ethos joins Credit Suisse pay revolt, demands change at top Reuters
Apr-06-17 08:30AM  Credit Suisse Announces Coupon Payments and Expected Coupon Payments on Credit Suisse X-Links Exchange Traded Notes (the "ETNs") PR Newswire
08:30AM  Credit Suisse Announces Coupon Amount on its Credit Suisse S&P MLP Index ETN (ticker symbol "MLPO") PR Newswire
Apr-05-17 11:31AM  Top 7 Energy Stocks to Own for 2017 TheStreet.com
09:18AM  Credit Suisse's Abib Sees Permian Basin's Value Rising Bloomberg Video
06:28AM  Swiss Still Unhappy About Omission from Bank Raid Process Bloomberg
06:28AM  Frustrated Swiss Stress Cooperation in Cases Like Credit Suisse Bloomberg
02:00AM  Credit Suisse scandal threatens Swiss efforts to clean up reputation Reuters
12:02AM  U.S. regulator fines Credit Suisse unit, adviser over improper investments Reuters
Apr-04-17 12:30PM  Credit Suisse scandal threatens Swiss efforts to clean up reputation
12:17PM  Credit Suisse Investors Urged to Reject `Excessive' Bonuses Bloomberg
09:04AM  FINMA talking to Credit Suisse about capital situation Reuters
04:51AM  Australian Credit Suisse Probe Covers Relatively Recent Accounts
04:49AM  FINMA says in contact with Credit Suisse after office raids
Apr-03-17 03:14PM  Credit Suisse Probe Puts Swiss Officials on Back Foot Again
03:14PM  Credit Suisse Probe Puts Swiss Authorities on Back Foot Again
10:18AM  Credit Suisse (CS) Faces Tax Fraud & Money Laundering Probes
08:21AM  Credit Suisse Tax Probe Complicates Thiam's Turnaround
08:21AM  Credit Suisse Tax Probe Complicates Thiam's Turnaround
07:31AM  European Bank Shares Dip as Rate Expectations Shift Amid Slowing Inflation
05:06AM  Credit Suisse's Problems May Not Stop With the Taxman
02:53AM  Credit Suisse in Five-Nation Tax Probe
12:00AM  Credit Suisse Said to Hire Deutsche Bank Equities Executives
Apr-02-17 07:58PM  Credit Suisse claims innocence in global press AFP
02:22PM  Thiams Turnaround Clouded by Tax Probe of Credit Suisse
02:22PM  Thiam's Turnaround Clouded by Tax Probe of Credit Suisse Offices
09:15AM  Credit Suisse Responds to Tax Probe in Two-Page Newspaper Ads
07:27AM  Credit Suisse takes out UK newspaper ads after office raids in tax case Reuters
Mar-31-17 05:50PM  [$$] Credit Suisse Rolls Out Management Changes at Secondary Advisory Unit at The Wall Street Journal
03:30PM  Credit Suisse launches internal investigation after offices searched in tax probe Reuters
01:12PM  Today's charts: Blackberry shares soar; Credit Suisse falls on tax probe; Starbucks tests mobile order-only store
12:22PM  [$$] Credit Suisse Contacted by Authorities Over Tax Issues at The Wall Street Journal
09:06AM  Analysts Latest Recommendations for Air Products & Chemicals
07:51AM  Early movers: DD, BBRY, JNJ, CS, AAPL, DANOY, WFC, AZN, VZ & more at CNBC
06:05AM  Herro Sees Most Opportunity in European Financials
05:32AM  Credit Suisse Says Offices in Three Cities Raided in Tax Matters
05:32AM  Credit Suisse Raided, Client Assets Seized in Tax Probe
01:34AM  Credit Suisse apparent target of massive tax fraud probe AFP
Mar-30-17 04:05PM  Credit Suisse AG Announces Its Intent To Suspend Further Issuances Of Its CSLS ETNs PR Newswire
01:04PM  CREDIT SUISSE GROUP AG Financials
10:37AM  Why Credit Suisse Thinks Iron Ore Prices Will Recover
09:33AM  Will Barclays Sell Zimbabwe Unit to First Merchant Bank? at Investopedia
Mar-29-17 01:30AM  Philippines Plans to Set Up a Bank in Bahrain
Mar-28-17 11:40AM  Credit Suisse Could Avoid IPO for Swiss Bank Unit at Investopedia
Mar-27-17 11:54PM  Credit Suisse's Garthwaite Sees Equities Creeping Upwards
09:32PM  Credit Suisse Progress Buys Thiam Breathing Room on Capital
09:32PM  Credit Suisse CEO Says Considering Options to Plug Capital Hole
09:14PM  Credit Suisse CEO Sees Brexit and Capital Options
08:41PM  Credit Suisse CEO Thiam Sees Options for Bank on Brexit
10:30AM  Credit Suisse Mulls Share Sale Instead of Swiss Unit IPO
09:24AM  Credit Suisse (CS) Increases Bonus to Retain Employees
Mar-26-17 08:29AM  [$$] Credit Suisse pays out SFr250m to retain top bankers and traders at Financial Times
Mar-24-17 01:14PM  [$$] Curious Quirks in How Credit Suisse Makes Money at The Wall Street Journal
12:54PM  Credit Suisse Boosts Bonus Pool by $3.1 Billion
12:25PM  [$$] Credit Suisse boosts bonuses despite large annual loss at Financial Times
07:26AM  Credit Suisse's Dilution a Capital Boost Concern
06:18AM  Credit Suisse CEO pockets $12 million despite back-to-back losses Reuters
02:26AM  Credit Suisse Increases Bonus Pool 6%, CEO Thiam Gets $12 Million
01:00AM  Keeping the Deutsche Wolf from Credit Suisse's Door
Mar-23-17 03:22PM  Credit Suisse Said to Weigh Stock Sale
01:11PM  European stocks break 3-day losing streak as investors eye U.S. health care vote at MarketWatch
12:46PM  Credit Suisse shares drop 2% on reports of $3 billion share sale at MarketWatch
11:28AM  Credit Suisse considers stock sale over Swiss IPO: sources Reuters
10:44AM  Credit Suisse Said Weighing Share Sale Over Swiss IPO
09:48AM  Credit Suisse Said to Weigh Stock Sale Instead of Swiss IPO
07:03AM  Swiss Fraud Probe May Expand to Include Credit Suisse Employees
Credit Suisse Group AG, together with its subsidiaries, provides various financial services worldwide. It operates through Swiss Universal Bank, International Wealth Management, Asia Pacific, Global Markets, and Investment Banking & Capital Markets segments. The company offers advisory and financial solutions, such as structured advisory, investment advisory, discretionary asset management, mergers and acquisitions transactions, corporate sales and restructurings, divestitures, takeover defense strategies, equity and fixed income sales, trading, debt and equity securities, spin-offs, debt and equity underwritings, private placements, and derivative products, as well as proprietary and third-party products and services. It also provides traditional and structured lending, payment, foreign exchange, capital goods leasing, trade finance, export finance, factoring, ship and aviation finance services; and fund solutions and fund-linked services. In addition, the company offers investment solutions and services to pension funds, governments, foundations and endowments, corporations, and individuals; and global securities sales, trading and execution, prime brokerage, and investment research services. It operates 401 offices and branches. The company offers its products and services to private, corporate, institutional, ultra-high-net-worth and high-net-worth individuals, small and medium-sized enterprises, institutional clients, and financial institutions, as well as affluent and retail clients. Credit Suisse Group AG was founded in 1856 and is based in Zurich, Switzerland.